Literature DB >> 31283592

Emergency Surgery for Obstructive Colon Cancer in Elderly Patients: Results of a Multicentric Cohort of the French National Surgical Association.

Gilles Manceau1, Diane Mege2, Valérie Bridoux3, Zaher Lakkis4, Aurélien Venara5, Thibault Voron6, Igor Sielezneff2, Mehdi Karoui1.   

Abstract

BACKGROUND: Although elderly patients constitute most of the patients undergoing surgery for obstructed colon cancer, available data in the literature are very limited.
OBJECTIVE: The purpose of this study was to assess the management and outcomes of elderly patients treated for obstructed colon cancer.
DESIGN: This was a multicenter, retrospective cohort study. SETTINGS: Between 2000 and 2015, 2325 patients managed for an obstructed colon cancer in member centers of the French National Surgical Association were identified. Data were collected by each center on a voluntary basis after institutional approval. Bowel obstruction was defined clinically and confirmed by imaging. PATIENTS: Three age groups were defined, including patients <75 years, 75 to 84 years, and ≥85 years. MAIN OUTCOME MEASURES: Postoperative and oncologic results in elderly patients with an obstructed colon cancer were measured. Relative survival was calculated as the ratio of the overall survival with the survival that would have been expected based on the corresponding general population.
INTERVENTIONS: A total of 302 patients (13%) underwent colonic stent insertion, and 1992 (87%) underwent surgery as emergency procedure.
RESULTS: A total of 2294 patients were analyzed (<75 y, n = 1200 (52%); 75-84 y, n = 650 (28%); and ≥85 y, n = 444 (20%)). Elderly patients were more likely to be women (p < 0.0001), to have proximal colon cancer (p < 0.0001), and to have a higher incidence of comorbidities (p < 0.0001). The use of colonic stent or the type of surgery was identical regardless of age. In patients with resected colon cancer, elderly patients had less stage IV disease (p < 0.0001). The absence of tumor resection (p < 0.0001) and definitive stoma rate increased with age (p < 0.0001). Postoperative mortality and morbidity were significantly higher in elderly patients (p < 0.0001), but surgical morbidity was similar across age groups (p = 0.60). Postoperative morbidity was correlated to the 6-month mortality rate in elderly (p < 0.0001). Overall and disease-free survivals were significantly lower in more elderly patients (p < 0.0001) but relative survival was not (p = 0.09). LIMITATIONS: It is quite difficult to know how to interpret these data as a whole, given the inherent bias in the study population, lack of ability to stratify by performance status, and long study period duration.
CONCLUSIONS: Elderly patients have high morbidity with lower survival in the highest age ranges of elderly subgroups. These data should be considered when deciding on an operative approach. See Video Abstract at http://links.lww.com/DCR/A964.

Entities:  

Mesh:

Year:  2019        PMID: 31283592     DOI: 10.1097/DCR.0000000000001421

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  Impact of hospital volume on outcomes after emergency management of obstructive colon cancer: a nationwide study of 1957 patients.

Authors:  Mathilde Aubert; Diane Mege; Gilles Manceau; Valérie Bridoux; Zaher Lakkis; Aurélien Venara; Thibault Voron; Solafah Abdalla; Laura Beyer-Berjot; Igor Sielezneff; Charles Sabbagh; Mehdi Karoui
Journal:  Int J Colorectal Dis       Date:  2020-06-05       Impact factor: 2.571

Review 2.  A Multidisciplinary Approach for the Personalised Non-Operative Management of Elderly and Frail Rectal Cancer Patients Unable to Undergo TME Surgery.

Authors:  Stijn H J Ketelaers; Anne Jacobs; An-Sofie E Verrijssen; Jeltsje S Cnossen; Irene E G van Hellemond; Geert-Jan M Creemers; Ramon-Michel Schreuder; Harm J Scholten; Jip L Tolenaar; Johanne G Bloemen; Harm J T Rutten; Jacobus W A Burger
Journal:  Cancers (Basel)       Date:  2022-05-11       Impact factor: 6.575

Review 3.  Perineural invasion is increased in patients receiving colonic stenting as a bridge to surgery: a systematic review and meta-analysis.

Authors:  I Balciscueta; Z Balciscueta; N Uribe; E García-Granero
Journal:  Tech Coloproctol       Date:  2020-11-17       Impact factor: 3.781

4.  Management of obstructive colon cancer: Current status, obstacles, and future directions.

Authors:  Ri-Na Yoo; Hyeon-Min Cho; Bong-Hyeon Kye
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

5.  Primary tumor location (right versus left side of the colon) and resection affect the survival of patients with liver metastases from colonic neuroendocrine carcinoma: a population-based study.

Authors:  Wen Cai; Weiting Ge; Jiawei Zhang; Siyuan Xie; Dehao Wu; Hanguang Hu; Jianshan Mao
Journal:  Therap Adv Gastroenterol       Date:  2021-10-29       Impact factor: 4.409

6.  Adult and Elderly Risk Factors of Mortality in 23,614 Emergently Admitted Patients with Rectal or Rectosigmoid Junction Malignancy.

Authors:  Lior Levy; Abbas Smiley; Rifat Latifi
Journal:  Int J Environ Res Public Health       Date:  2022-07-27       Impact factor: 4.614

7.  Colon cancer patient with long-term colon stent placement: Case report and literature review.

Authors:  Qing Huang; Min-Hong Zou; Wen-Long Liang; Jian-Chang Wei; Jie-Feng Xie; Yong-Qiang Li; Wang-Lin Li; Jie Cao
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

8.  Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.

Authors:  Jing Liang; Xiao-Feng Tian; Wei Yang
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

9.  Comparison of Clinical Outcomes and Pathological Characteristics of Self-Expandable Stent Bridge to Surgery and Emergency Surgery in Obstructive Colon Cancer.

Authors:  Bingyan Wang; Siyi Lu; Zhiqiang Song; Fei Li; Junren Ma; Yanpeng Ma; Xin Zhou; Wei Fu
Journal:  Cancer Manag Res       Date:  2020-03-09       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.